These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1636280)

  • 1. [Antibodies to neutrophilic granulocytes (p-ANCA): a further indication for a common origin of ulcerative colitis and primary sclerosing cholangitis?].
    Jahn HU; Zeitz M
    Z Gastroenterol; 1992 Jun; 30(6):441-2. PubMed ID: 1636280
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoantibodies in chronic inflammatory bowel diseases: more than an epiphenomenon?].
    Folwaczny C; Fricke H
    Z Gastroenterol; 1998 Jan; 36(1):105-8. PubMed ID: 9531690
    [No Abstract]   [Full Text] [Related]  

  • 3. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.
    Tervaert JW; Mulder AH; Horst G; Haagsma EB; Kleibeuker JH; Kallenberg CG
    Gastroenterology; 1992 Mar; 102(3):1090-1. PubMed ID: 1537508
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticytoplasmic auto-antibodies of polynuclear neutrophils: a common biologic marker in hemorrhagic rectocolitis and primary sclerosing cholangitis].
    Jacquot S
    Gastroenterol Clin Biol; 1991; 15(12):990-1. PubMed ID: 1783264
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
    Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
    Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
    Bansi DS; Lo S; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):111-6. PubMed ID: 8723413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
    Seibold F; Slametschka D; Gregor M; Weber P
    Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
    Vidrich A; Lee J; James E; Cobb L; Targan S
    J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.
    Zauli D; Baffoni L; Cassani F; Fusconi M; Lenzi M; Ballardini G; Luigi M; Bianchi FB; Schrumpf E
    Gastroenterology; 1992 Mar; 102(3):1088-90. PubMed ID: 1537507
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.
    Haagsma EB; Mulder AH; Gouw AS; Horst G; Meerman L; Slooff MJ; Kallenberg CG
    J Hepatol; 1993 Aug; 19(1):8-14. PubMed ID: 8301047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
    Peen E; Almer S; Bodemar G; Rydén BO; Sjölin C; Tejle K; Skogh T
    Gut; 1993 Jan; 34(1):56-62. PubMed ID: 8432453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
    Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
    Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon?
    Chapman RW
    Hepatology; 1995 May; 21(5):1473-4. PubMed ID: 7737656
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis.
    Mehal WZ; Lo SK; Chapman RW; Fleming KA
    J Hepatol; 1994 Nov; 21(5):910-1. PubMed ID: 7890911
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary sclerosing cholangitis].
    Hauschild S; Gross WL
    Dtsch Med Wochenschr; 1992 Jan; 117(5):197-8. PubMed ID: 1735382
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
    Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ANCA (antineutrophil cytoplasm antibodies)].
    Katz S
    Acta Gastroenterol Latinoam; 1994; 24(1):61-3. PubMed ID: 8059593
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
    Halbwachs-Mecarelli L; Nusbaum P; Noël LH; Reumaux D; Erlinger S; Grünfeld JP; Lesavre P
    Clin Exp Immunol; 1992 Oct; 90(1):79-84. PubMed ID: 1327593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.